Case Report: Reversal of Integrase Inhibitor– and Tenofovir Alafenamide–Related Weight Gain After Switching Back to Efavirenz/Emtricitabine/Tenofovir DF

We report a case of substantial weight gain in a virologically suppressed patient with HIV after changing his antiretroviral therapy from efavirenz/emtricitabine/tenofovir DF to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide with subsequent rapid weight loss upon switching back. The rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Pohlman, F Will, McGee, Kara S, McKellar, Mehri S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Novel ID Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379714/
https://www.ncbi.nlm.nih.gov/pubmed/34430674
http://dx.doi.org/10.1093/ofid/ofab403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379714/
https://www.ncbi.nlm.nih.gov/pubmed/34430674
http://dx.doi.org/10.1093/ofid/ofab403

Ejemplares similares